Superselective intra-arterial chemoradiation therapy for functional laryngeal preservation in advanced squamous cell carcinoma of the glottic larynx

Acta Oto-Laryngologica

Volumn 133, Issue 6, 2013, Pages 633-640

  Furusaka, Tohru ^a,b   Matsuda, Akira ^b   Tanaka, Akane ^b   Matsuda, Hiroshi ^b   Ikeda, Minoru ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Cisplatin; Docetaxel; Laryngeal cancer; Quality of life; Total laryngectomy

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; HEMOGLOBIN; HYDROCORTISONE; SODIUM THIOSULFATE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CHEMORADIOTHERAPY; CONTINUOUS INFUSION; DERMATITIS; DRUG DOSE REDUCTION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDUCTION CHEMOTHERAPY; IRON DEFICIENCY ANEMIA; LARYNGECTOMY; LARYNX SQUAMOUS CELL CARCINOMA; LEUKOCYTE COUNT; LEUKOPENIA; LIVER DYSFUNCTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NECK DISSECTION; NEUTROPENIA; NEUTROPHIL COUNT; ORGAN PRESERVATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; SIDE EFFECT; SURVIVAL RATE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; FEMALE; FLUOROURACIL; GLOTTIS; HUMANS; INFUSIONS, INTRA-ARTERIAL; JAPAN; KAPLAN-MEIER ESTIMATE; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; MIDDLE AGED; TAXOIDS;

EID: 84877888991     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.3109/00016489.2012.759275     Document Type: Article

References (20)

1. Breitbart WS, Holland JC. 1989. Head and neck cancer. In Holland JC, Rowland JH, editors. Handbook of psycho-oncology: psychological care of the patient with cancer. New York: Oxford University Press. p 232-9.
2. Adelstein DJ, Lavertu P, Saxton JP, Secic M, Wood BG, Wanamaker JR, et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 2000;88:876-83.
3. Lefebvre J-L. Current clinical outcomes demand new treatment options for SCCHN. Ann Oncol 2005;16:vi7-vi12.
4. Pignon JP, Bourthis J, Domenge C, Desibné L; On behalf of the MACH-NC Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000;355:949-55
5. Japan Society for Head and Neck Cancer. editors. 2009; Clinical Practice Guideline for Head and Neck Cancer. Tokyo: Kanehara & Co. Ltd. p 25-30; in Japanese
6. National Comprehensive Cancer Network. http://www.nccn. org/professionals/physician-gls/f-guidelines.asp.
7. National Cancer Institute. http:/www.cancer.gov/cancerto-pics/pdq/ cancerdatabase.
8. Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK, et al. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 2006;24:3693-704.
9. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007;357:1695-704.
10. Postner MR, Hershock DM, Blajiman CR, Mackiewitz E, Winquist E, Gorbounova V, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:1705-15.
11. Paccagnella A, Orland A, Marchiori C, Zorat PL, Cavaniglia G, Sileni VC, et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 1994;86:265-72.
12. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryn-geal cancer. N Engl J Med 1997;324:1685-90.
13. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-8.
14. Richard JM, Sancho-Garnier H, Pessey JJ, Luboinski B, Lefebvre JL, Dehesdin D, et al. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 1998;34: 224-8.
15. Gourin CG, Conger BT, Sheils WC, Bilodeau PA, Coleman TA, Porubsky ES. The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 2009;119:1312-17.
16. Furusaka T, Matsuda H, Saito T, Katsura Y, Ikeda M. Long term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone. Acta Otolaryngol 2012;132:546-51.
17. Staton J, Robbins KT, Newman L, Samant S, Sebelik M, Vieira F. Factors predictive of poor functional outcome after chemoradiation for advanced laryngeal cancer. Otolaryngol Head Neck Surg 2002;127:43-7.
18. Robbins KT, Storniolo AM, Kerber C, Seagren S, Berson A, Howell SB. Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck 1992; 14:364-71.
19. Rasch CR, Haupmann M, Schornagel J, Wijers O, Buter J, Gregor T, et al. Intra-arterial versus intravenous chemora-diation for advanced head and neck cancer: results of a randomized phase 3 trial. Cancer 2010;98:2159-65.
20. Furusaka T, Asakawa T, Tanaka A, Matsuda M, Ikeda M. Efficacy of multidrug superselective intra-arterial chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) using the Sel-dinger technique for tongue cancer. Acta Otolaryngol 2012; 132:1108-14.